(17(10)):e94734 doi:10.7759/cureus.94734
Semaglutide, also known as Ozempic and Wegovy, is one of the leading medications for sustainable weight loss, offering meaningful results without requiring extreme diets or deprivation
Originally developed in Australia in the 1990s, it was designed to harness the fat-burning properties of growth hormone without triggering its broader hormonal effects
Most patients experience brief discomfort during or immediately after injection that resolves within minutes to hours
Following your doctor's guidance is essential
141 Besides, the phase IIb study of a novel granulocytemacrophage colony-stimulating factor (GM-CSF) receptor alpha monoclonal antibody, mavrilimumab, showed meaningful response by representing a novel mechanism